Gennaro Ciliberto

Gennaro Ciliberto's AcademicInfluence.com Rankings

Gennaro Ciliberto

Philosophy

#5860

World Rank

#8782

Historical Rank

Logic

#3067

World Rank

#4173

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Gennaro Ciliberto's Degrees

Doctorate Medicine University of Naples Federico II
PhD Medical Oncology University of Naples Federico II

Why Is Gennaro Ciliberto Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gennaro Ciliberto's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. (1999) (1730)
Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice (1996) (1510)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study (2018) (1224)
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. (1997) (1118)
Elevated levels of interleukin-6 in unstable angina. (1996) (789)
Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion. (1994) (745)
Interleukin 6 Is Required for the Development of Collagen-induced Arthritis (1998) (641)
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. (1997) (511)
The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells (2009) (383)
Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. (1999) (332)
Increased toxin‐induced liver injury and fibrosis in interleukin‐6–deficient mice (2000) (310)
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy (2014) (307)
Interleukin-6 Protects against Fas-mediated Death by Establishing a Critical Level of Anti-apoptotic Hepatic Proteins FLIP, Bcl-2, and Bcl-xL* (2001) (296)
Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation (2004) (283)
Transcription by RNA polymerase III. (1983) (269)
CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. (1998) (261)
Dual control of C‐reactive protein gene expression by interleukin‐1 and interleukin‐6. (1989) (249)
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma (2014) (240)
Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer. (2014) (223)
Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells. (1998) (222)
Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance. (1997) (210)
Two distinct and independent sites on IL‐6 trigger gp 130 dimer formation and signalling. (1995) (201)
Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes. (1988) (196)
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. (1999) (168)
The human alpha 1‐antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes. (1987) (168)
Extramedullary Expansion of Hematopoietic Progenitor Cells in Interleukin (IL)-6–sIL-6R Double Transgenic Mice (1997) (166)
Comparative expression pathway analysis of human and canine mammary tumors (2009) (163)
Constitutive and IL‐6‐induced nuclear factors that interact with the human C‐reactive protein promoter. (1990) (162)
IL‐6 Expression in Neurons of Transgenic Mice Causes Reactive Astrocytosis and Increase in Ramified Microglial Cells but no Neuronal Damage (1995) (160)
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope. (2005) (156)
The two C/EBP isoforms, IL6DBP/NFIL6 and CEBP6δ/NFIL63, are induced by IL6β to promote acute phase gene transcription via different mechanisms (1993) (152)
Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. (1998) (147)
Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure. (2008) (145)
Coexpression of IL‐6 and soluble IL‐6R causes nodular regenerative hyperplasia and adenomas of the liver (1998) (141)
Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution (2021) (140)
Triple negative breast cancer: looking for the missing link between biology and treatments (2015) (140)
Single-step purification and structural characterization of human interleukin-6 produced in Escherichia coli from a T7 RNA polymerase expression vector. (1991) (139)
IL-6 Is Required for Airway Mucus Production Induced by Inhaled Fungal Allergens1 (2009) (138)
Structural analysis of the epitope of the anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion. (2003) (135)
Rational design of a receptor super‐antagonist of human interleukin‐6. (1994) (132)
Interleukin-6-Induced STAT3 and AP-1 Amplify Hepatocyte Nuclear Factor 1-Mediated Transactivation of Hepatic Genes, an Adaptive Response to Liver Injury (2001) (132)
Synergistic trans‐activation of the human C‐reactive protein promoter by transcription factor HNF‐1 binding at two distinct sites. (1990) (129)
Gene therapy progress and prospects: transcription regulatory systems (2004) (128)
Role of IL-6 in the pleurisy and lung injury caused by carrageenan. (1999) (128)
Inducible and tissue‐specific expression of human C‐reactive protein in transgenic mice. (1987) (128)
IL‐6 Mediates the Effects of IL‐1 or TNF, but Not PTHrP or 1,25(OH)2D3, on Osteoclast‐like Cell Formation in Normal Human Bone Marrow Cultures (1998) (128)
Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015 (2016) (125)
Common and interchangeable elements in the promoters of genes transcribed by RNA polymerase III (1983) (123)
Generation of interleukin‐6 receptor antagonists by molecular‐modeling guided mutagenesis of residues important for gp130 activation. (1994) (123)
Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. (1994) (118)
Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice. (1997) (118)
The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment (2013) (113)
Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells (2013) (113)
Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine (2021) (112)
Global changes in interleukin‐6–dependent gene expression patterns in mouse livers after partial hepatectomy (2001) (111)
Site-Specific Integration in Mammalian Cells Mediated by a New Hybrid Baculovirus–Adeno-Associated Virus Vector (1998) (108)
Cis‐ and trans‐acting elements responsible for the cell‐specific expression of the human alpha 1‐antitrypsin gene. (1987) (104)
Cell-specific expression of a transfected human α1 -antitrypsin gene (1985) (103)
Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy? (2016) (101)
In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway (1998) (101)
Modulation of the Immune Response Induced by Gene Electrotransfer of a Hepatitis C Virus DNA Vaccine in Nonhuman Primates (2006) (98)
Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells. (1996) (98)
Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activators. (2002) (97)
Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs (2010) (96)
miR-579-3p controls melanoma progression and resistance to target therapy (2016) (95)
Structure of the human α1acid glycoprotein gene: sequence homology with other human acute phase protein genes (1985) (95)
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden. (2020) (94)
Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice. (1998) (93)
An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus (2001) (92)
Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure. (2000) (92)
Metabolic features of cancer stem cells: the emerging role of lipid metabolism (2018) (91)
MicroRNAs in melanoma development and resistance to target therapy (2017) (90)
Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector. (2000) (87)
Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ (2017) (86)
IL‐6 knock‐out mice exhibit resistance to splanchnic artery occlusion shock (1999) (86)
Blocking signaling through the gp130 receptor chain by interleukin‐6 and oncostatin M inhibits PC‐3 cell growth and sensitizes the tumor cells to etoposide and cisplatin‐mediated cytotoxicity (1999) (85)
Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions. (1998) (82)
The promise of anti-ErbB3 monoclonals as new cancer therapeutics (2012) (80)
Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer. (2020) (79)
Gene electro‐transfer improves transduction by modifying the fate of intramuscular DNA (2003) (78)
Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors (2013) (77)
Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells. (2017) (77)
Universal Influenza B Vaccine Based on the Maturational Cleavage Site of the Hemagglutinin Precursor (2005) (76)
Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system (2002) (75)
Anti‐inflammatory actions of an N‐terminal peptide from human lipocortin 1 (1993) (75)
Construction of an rtTA2s-m2/ttskid-Based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and Non-Human primates (2003) (75)
Efficient induction of T‐cell responses to carcinoembryonic antigen by a heterologous prime‐boost regimen using DNA and adenovirus vectors carrying a codon usage optimized cDNA (2005) (75)
Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ (2017) (73)
Regulation of the human C-reactive protein gene, a major marker of inflammation and cancer. (1990) (71)
MMP11: A Novel Target Antigen for Cancer Immunotherapy (2009) (70)
Saturation mutagenesis of the human interleukin 6 receptor-binding site: implications for its three-dimensional structure. (1993) (70)
Identification of sequences responsible for acute-phase induction of human C-reactive protein. (1988) (69)
Gene electro‐transfer of an improved erythropoietin plasmid in mice and non‐human primates (2005) (69)
The affinity‐selection of a minibody polypeptide inhibitor of human interleukin‐6. (1994) (67)
Hyaluronidase increases electrogene transfer efficiency in skeletal muscle. (2002) (67)
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives (2019) (65)
Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway. (2015) (65)
Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy (2015) (65)
Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death. (1996) (64)
Liver-Specific Alpha 2 Interferon Gene Expression Results in Protection from Induced Hepatitis (2000) (64)
A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphoma. (2010) (63)
Impaired Stat3 activation following localized inflammatory stimulus in IL-6-deficient mice. (1998) (63)
Functional Expression of Soluble Human Interleukin-11 (IL-11) Receptor α and Stoichiometry of in Vitro IL-11 Receptor Complexes with gp130* (1996) (62)
The perfect personalized cancer therapy: cancer vaccines against neoantigens (2018) (61)
Presence of a reduced opioid response in interleukin‐6 knock out mice (1999) (60)
The two C/EBP isoforms, IL-6DBP/NF-IL6 and C/EBP delta/NF-IL6 beta, are induced by IL-6 to promote acute phase gene transcription via different mechanisms. (1993) (60)
Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition (2016) (59)
Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies (2013) (59)
IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients (2017) (58)
Helper‐dependent adenovirus for the gene therapy of proliferative retinopathies: stable gene transfer, regulated gene expression and therapeutic efficacy (2007) (58)
Genetic cancer vaccines: current status and perspectives (2012) (58)
Spheres Derived from Lung Adenocarcinoma Pleural Effusions: Molecular Characterization and Tumor Engraftment (2011) (58)
Promoter of a eukaryotic tRNAPro gene is composed of three noncontiguous regions. (1982) (57)
Interleukin 18: friend or foe in cancer. (2013) (57)
In vitro binding of ciliary neurotrophic factor to its receptors: evidence for the formation of an IL-6-type hexameric complex. (1995) (57)
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop (2019) (57)
Decreased expression of autophagic beclin 1 protein in idiopathic pulmonary fibrosis fibroblasts (2013) (57)
Obesity may hamper SARS-CoV-2 vaccine immunogenicity (2021) (56)
Constitutive and modulated expression of the human alpha 1 antitrypsin gene. Different transcriptional initiation sites used in three different cell types. (1992) (55)
Combinatorial immunotherapy strategies for hepatocellular carcinoma. (2016) (55)
A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines (2009) (55)
Engineering human interleukin‐6 to obtain variants with strongly enhanced bioactivity. (1996) (54)
Future perspectives in melanoma research (2016) (54)
Drug repurposing against COVID-19: focus on anticancer agents (2020) (54)
Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors. (1994) (53)
IL-6 is an in vitro and in vivo autocrine growth factor for middle T antigen-transformed endothelial cells. (1996) (52)
Lung Cancer Stem Cell Lose Their Stemness Default State after Exposure to Microgravity (2014) (51)
Overexpression of interleukin-6 in the central nervous system of transgenic mice increases central but not systemic proinflammatory cytokine production (1996) (51)
Development of Animal Models for Adeno-Associated Virus Site-Specific Integration (1999) (50)
Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primates. (2003) (49)
Transcription signals in embryonic Xenopus laevis U1 RNA genes. (1985) (49)
Coupling protein design and in vitro selection strategies: improving specificity and affinity of a designed beta-protein IL-6 antagonist. (1996) (49)
Soluble IL-6 receptor leads to a paracrine modulation of the IL-6-induced hepatic acute phase response in double transgenic mice. (1997) (48)
Mutations in the KEAP1-NFE2L2 pathway define a molecular subset of rapidly progressing lung adenocarcinoma. (2019) (47)
Potential Anticancer Effects of Polyphenols from Chestnut Shell Extracts: Modulation of Cell Growth, and Cytokinomic and Metabolomic Profiles (2016) (47)
Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations (2018) (47)
Role of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma (2015) (47)
Treatment of Mammary Carcinomas in HER-2 Transgenic Mice through Combination of Genetic Vaccine and an Agonist of Toll-Like Receptor 9 (2009) (46)
Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor. (2005) (46)
Standardized Index of Shape (SIS): a quantitative DCE-MRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC (2015) (46)
In Vivo Neutralization of Human IL-6 (hIL-6) Achieved by Immunization of hIL-6-Transgenic Mice with a hIL-6 Receptor Antagonist1 (2001) (46)
T-cell agonists in cancer immunotherapy (2020) (45)
Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma (2018) (45)
Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study (2015) (45)
Boosting the arsenal against COVID-19 through computational drug repurposing (2020) (45)
Electro-Gene-Transfer: A New Approach for Muscle Gene Delivery (2002) (45)
Comparative effects of nifedipine, verapamil, isosorbide dinitrate and propranolol on exercise-induced angina pectoris. (1979) (44)
Involvement of the Arg179 in the active site of human IL-6. (1993) (44)
Identification and Characterization of a Novel Nuclear Factor of Activated T-cells-1 Isoform Expressed in Mouse Brain* (2001) (43)
A novel method for site‐directed mutagenesis: its application to an eukaryotic tRNAPro gene promoter. (1982) (43)
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma (2018) (43)
Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity (2016) (43)
Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences (2017) (43)
Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer. (2008) (43)
Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay. (2004) (43)
Telomerase and HER-2/neu as targets of genetic cancer vaccines in dogs. (2010) (42)
Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”: Napoli, December 3rd–6th 2014 (2013) (42)
Strategies for improving the management of immune-related adverse events (2020) (42)
DNA and adenoviral vectors encoding carcinoembryonic antigen fused to immunoenhancing sequences augment antigen-specific immune response and confer tumor protection. (2005) (42)
Relationship between the two components of the split promoter of eukaryotic tRNA genes. (1982) (41)
Immunogenicity and safety of a DNA prime/adenovirus boost vaccine against rhesus CEA in nonhuman primates (2007) (41)
Therapeutic vaccination halts disease progression in BALB-neuT mice: the amplitude of elicited immune response is predictive of vaccine efficacy. (2008) (39)
Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma. (2013) (39)
Regulated and prolonged expression of mIFNα in immunocompetent mice mediated by a helper-dependent adenovirus vector (2002) (39)
Binding of a liver-specific factor to the human albumin gene promoter and enhancer (1990) (38)
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models (2021) (38)
Structure and expression of a Xenopus gene encoding an snRNP protein (U1 70K). (1988) (38)
Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist (1997) (38)
Vectors encoding carcinoembryonic antigen fused to the B subunit of heat-labile enterotoxin elicit antigen-specific immune responses and antitumor effects. (2007) (37)
In vivo DNA gene electro‐transfer: a systematic analysis of different electrical parameters (2005) (36)
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer (2013) (36)
Growth delay of human bladder cancer cells by Prostate Stem Cell Antigen downregulation is associated with activation of immune signaling pathways (2010) (36)
Novel anti‐ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors (2012) (36)
Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience (2013) (36)
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment (2014) (36)
The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells (2015) (36)
Interleukin-6 involvement in antidepressant action of Hypericum perforatum. (2001) (36)
Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma (2019) (35)
Formation of the 3′ end on U snRNAs requires at least three sequence elements. (1986) (35)
Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients (2014) (34)
Inhibition of eukaryotic tRNA transcription by potential Z‐DNA sequences. (1984) (33)
Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012” (2013) (33)
Interleukin-6 (IL-6) Antagonism by Soluble IL-6 Receptor Mutated in the Predicted gp130-binding Interface (*) (1995) (33)
Conditional Site-Specific Integration into Human Chromosome 19 by Using a Ligand-Dependent Chimeric Adeno-Associated Virus/Rep Protein (2000) (33)
Mutations in box B of the promoter of a eucaryotic tRNAPro gene affect rate of transcription, processing, and stability of the transcripts (1984) (32)
Loss of heterozygosity of imprinted genes in SV40 t/T antigen-induced hepatocellular carcinomas. (1995) (32)
Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma (2015) (32)
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience. (2017) (32)
TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung (2013) (32)
EMT markers in lung adenocarcinoma pleural effusion spheroid cells (2013) (32)
Susceptibility to audiogenic seizure and neurotransmitter amino acid levels in different brain areas of IL-6-deficient mice (2004) (31)
Neoadjuvant chemotherapy in triple‐negative breast cancer: A multicentric retrospective observational study in real‐life setting (2018) (31)
Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia (2021) (31)
Definition of a Composite Binding Site for gp130 in Human Interleukin-6 (*) (1995) (31)
Elevation of IL-6 in transgenic mice results in increased levels of the 90 kDa heat shock protein (hsp90) and the production of anti-hsp90 antibodies. (1998) (31)
Anti-EphA2 Antibodies with Distinct In Vitro Properties Have Equal In Vivo Efficacy in Pancreatic Cancer (2010) (30)
Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth (2019) (29)
Purification of pseudouridylate synthetase I from Salmonella typhimurium. (1978) (29)
An Adenovirus Type 5 (Ad5) Amplicon-Based Packaging Cell Line for Production of High-Capacity Helper-Independent ΔE1-E2-E3-E4 Ad5 Vectors (2005) (28)
Homeodomain‐interacting protein kinase2 in human idiopathic pulmonary fibrosis (2013) (28)
Cell-specific expression of a transfected human alpha 1-antitrypsin gene. (1985) (28)
Antibody Persistence 6 Months Post-Vaccination with BNT162b2 among Health Care Workers (2021) (28)
Long-term and tight control of gene expression in mouse skeletal muscle by a new hybrid human transcription factor. (2002) (28)
microRNA-378a-5p iS a novel positive regulator of melanoma progression (2020) (28)
Kinesin spindle protein SiRNA slows tumor progression (2013) (28)
Monovalent phage display of human interleukin (hIL)-6: selection of superbinder variants from a complex molecular repertoire in the hIL-6 D-helix. (1995) (28)
Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trial (2013) (27)
Early Onset of SARS-COV-2 Antibodies after First Dose of BNT162b2: Correlation with Age, Gender and BMI (2021) (27)
Immune responses against tetracycline‐dependent transactivators affect long‐term expression of mouse erythropoietin delivered by a helper‐dependent adenoviral vector (2005) (27)
Monoclonal antibody-induced ErbB3 receptor internalization and degradation inhibits growth and migration of human melanoma cells (2012) (27)
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study (2018) (27)
CCAAT Enhancer – binding Protein b Is Required for Normal Hepatocyte Proliferation in Mice after Partial Hepatectomy (1998) (27)
Cancer vaccination by electro-gene-transfer (2013) (27)
SCD1, autophagy and cancer: implications for therapy (2021) (27)
Synergistic induction of growth arrest and apoptosis of human myeloma cells by the IL-6 super-antagonist Sant7 and Dexamethasone (2000) (27)
Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model (2015) (26)
Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer. (2017) (26)
Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial (2017) (26)
Properties of a U1 RNA enhancer-like sequence. (1987) (25)
CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR (2016) (25)
Environment and bladder cancer: molecular analysis by interaction networks. (2017) (25)
Identification and Validation of HCC-specific Gene Transcriptional Signature for Tumor Antigen Discovery (2016) (25)
Anti-Inflammatory Effects of a Methanol Extract from the Marine Sponge Geodia cydonium on the Human Breast Cancer MCF-7 Cell Line (2015) (25)
Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review (2016) (25)
Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric Carcinogenesis (2016) (24)
Selective Cleavage of AAVS1 Substrates by the Adeno-Associated Virus Type 2 Rep68 Protein Is Dependent on Topological and Sequence Constraints (2000) (24)
The need for a network to establish and validate predictive biomarkers in cancer immunotherapy (2017) (24)
An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models (2009) (24)
Antitumor activity of recombinant adenoviral vectors expressing murine IFN-α in mice injected with metastatic IFN-resistant tumor cells (2001) (24)
MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma. (2017) (23)
A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent (2004) (23)
Serum Cytokinome Profile Evaluation: A Tool to Define New Diagnostic and Prognostic Markers of Cancer Using Multiplexed Bead-Based Immunoassays (2016) (23)
Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study (2018) (23)
Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem–Like Cells and Reduces Metastases through Effects on Lipid Anabolism (2020) (23)
Synthesis and anti-hepatitis C virus activity of novel ethyl 1H-indole-3-carboxylates in vitro. (2010) (22)
Inducible formation of liver tumors in transgenic mice. (1993) (22)
TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients (2020) (22)
Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research. (2016) (22)
Electro-gene-transfer as a new tool for cancer immunotherapy in animals. (2014) (22)
Analysis of human/mouse interleukin‐6 hybrid proteins: both amino and carboxy termini of human interleukin‐6 are required for in vitro receptor binding (1992) (22)
Phenotype characterization of human melanoma cells resistant to dabrafenib (2017) (21)
ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma: Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin (2019) (21)
Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future Perspectives (2020) (21)
Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype (2014) (21)
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience (2017) (20)
CD8+ T‐Cell Tolerance can be Broken by an Adenoviral Vaccine While CD4+ T‐Cell Tolerance is Broken by Additional Co‐administration of a Toll‐Like Receptor Ligand (2006) (20)
Coadministration of telomerase genetic vaccine and a novel TLR9 agonist in nonhuman primates. (2009) (20)
Human MiR-544a Modulates SELK Expression in Hepatocarcinoma Cell Lines (2016) (20)
Alu sequences transcription in X. laevis oocytes: nuclear-cytoplasmic partitioning and evidence for 3' end processing reactions. (1985) (20)
Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research (2017) (19)
Corrigendum: Lymphoproliferative disorder and imbalanced T-helper response in C/EBPβ-deficient mice (The Embo Journal (1995) 14 (1932-1941)) (1995) (19)
Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”, Napoli, December 5th-8th 2013 (2014) (19)
Genetic and Functional Analysis of Polymorphisms in the Human Dopamine Receptor and Transporter Genes in Small Cell Lung Cancer (2016) (19)
CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions (2019) (19)
Immunogenicity and therapeutic efficacy of a dual-component genetic cancer vaccine cotargeting carcinoembryonic antigen and HER2/neu in preclinical models. (2014) (19)
The emerging role of cancer cell plasticity and cell-cycle quiescence in immune escape (2020) (19)
CD4+CD25+ regulatory T-cell-inactivation in combination with adenovirus vaccines enhances T-cell responses and protects mice from tumor challenge (2007) (19)
Carnitines slow down tumor development of colon cancer in the DMH‐chemical carcinogenesis mouse model (2013) (19)
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor‐positive, advanced breast cancer: A real‐world experience (2018) (19)
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study (2020) (19)
Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma (2018) (18)
Antiapoptotic small interfering RNA as potent adjuvant of DNA vaccination in a mouse mammary tumor model. (2009) (18)
Emerging Cancer Vaccines: The Promise of Genetic Vectors (2011) (18)
Cell cycle regulation and induction of apoptosis by IL-6 variants on the multiple myeloma cell line XG-1 (1999) (18)
A general method to select for M13 clones carrying base pair substitution mutants constructed in vitro. (1983) (18)
High circulating levels of biologically inactive IL‐6/SIL‐6 receptor complexes in systemic juvenile idiopathic arthritis: evidence for serum factors interfering with the binding to gp130 (2003) (17)
Tumor biobanks in translational medicine (2012) (17)
A therapeutic cancer vaccine targeting carcinoembryonic antigen in intestinal carcinomas. (2008) (17)
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome (2018) (17)
Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition (2020) (17)
Internal deletions of amino acids 29‐42 of human interleukin‐6 (IL‐6) differentially affect bioactivity and folding (1991) (17)
Expression of the murine interleukin 6 receptor in hepatoma cells: the intracytoplasmic domain is not required for interleukin 6 signal transduction (1992) (17)
Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression (2016) (17)
Transcriptional regulation of acute phase genes by IL-6 and related cytokines. (1994) (16)
A TLR9 agonist enhances therapeutic effects of telomerase genetic vaccine. (2010) (16)
Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin’s lymphomas (2021) (16)
Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study (2020) (16)
Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting (2017) (16)
ErbB2 genetic cancer vaccine in nonhuman primates: relevance of single nucleotide polymorphisms. (2008) (16)
KEAP1 and TP53 frame genomic, evolutionary and immunological subtypes of lung adenocarcinoma with different sensitivity to immunotherapy. (2021) (16)
Synergistic Stimulation of Interleukin 6 Release and Gene Expression by Phorbol Esters and Interleukin 1β in Rat Cortical Astrocytes: Role of Protein Kinase C Activation and Blockade (1995) (16)
A Multimeric Synthetic Peptide Combinatorial Library. (1994) (16)
COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial (2021) (16)
Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response (2021) (16)
Characterization of mononuclear-phagocyte terminal maturation by mRNA phenotyping using a set of cloned cDNA probes. (1989) (16)
The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression (2018) (16)
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas (2017) (16)
Structural characterization of a biologically active human lipocortin 1 expressed in Escherichia coli. (1993) (16)
Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracy (2019) (16)
Transcriptional Regulation of Acute Phase Response Genes with Emphasis on the Human C-reactive Protein Gene (1989) (16)
Xenogene vaccination in the therapy of cancer (2014) (16)
Future perspectives in melanoma research “Melanoma Bridge”, Napoli, November 30th–3rd December 2016 (2017) (16)
Neoadjuvant Immune-Checkpoint Blockade in Triple-Negative Breast Cancer: Current Evidence and Literature-Based Meta-Analysis of Randomized Trials (2020) (15)
A novel minigene scaffold for therapeutic cancer vaccines (2014) (15)
The 12‐week kinetics of anti‐SARS‐CoV‐2 antibodies in different haematological cancers after vaccination with BNT162b2 (2021) (15)
Combining doxorubicin with a phenolic extract from flaxseed oil: Evaluation of the effect on two breast cancer cell lines. (2017) (15)
An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platform (2012) (15)
A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice (2016) (15)
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab (2018) (15)
Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells (2017) (15)
A Novel Mouse Model for Evaluation and Prediction of HLA-A2-restricted CEA Cancer Vaccine Responses (2009) (15)
Pazopanib in Metastatic Renal Cancer: A “Real-World” Experience at National Cancer Institute “Fondazione G. Pascale” (2016) (15)
Differential Response of Two Human Breast Cancer Cell Lines to the Phenolic Extract from Flaxseed Oil † (2016) (15)
Regulated and Liver-Specific Tamarin Alpha Interferon Gene Delivery by a Helper-Dependent Adenoviral Vector (2005) (15)
WT1 CpG islands methylation in human lung cancer: a pilot study. (2012) (14)
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy (2018) (14)
Structure of the human alpha 1-acid glycoprotein gene: sequence homology with other human acute phase protein genes. (1985) (14)
Are Genetic Vaccines the Right Weapon against COVID-19? (2020) (14)
Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian “Real-World” SAX Study (2016) (14)
A functionally orthogonal estrogen receptor-based transcription switch specifically induced by a nonsteroid synthetic ligand. (2005) (13)
Biological mechanisms linked to inflammation in cancer: Discovery of tumor microenvironment-related biomarkers and their clinical application in solid tumors (2020) (13)
Internal deletions in human interleukin-6: structure-function analysis. (1991) (13)
A structure-guided approach to an orthogonal estrogen-receptor-based gene switch activated by ligands suitable for in vivo studies. (2006) (13)
Neoantigen cancer vaccine augments anti-CTLA-4 efficacy (2022) (13)
Effects of IL-6 Variants in Multiple Myeloma: Growth Inhibition and Induction of Apoptosis in Primary Cells (2002) (13)
Melanoma and immunotherapy bridge 2015 (2016) (13)
Intratumor RNA interference of cell cycle genes slows down tumor progression (2011) (12)
Isolation of Fully Human Antagonistic RON Antibodies Showing Efficient Block of Downstream Signaling and Cell Migration. (2011) (12)
Neurotrophin system activation in pleural effusions (2010) (12)
Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression (2017) (12)
Environment and bladder cancer: molecular analysis by interaction networks (2017) (12)
In Vitro Biophysical and Biological Characterization of Lipid Nanoparticles Co-Encapsulating Oncosuppressors miR-199b-5p and miR-204-5p as Potentiators of Target Therapy in Metastatic Melanoma (2020) (12)
Bringing Greater Accuracy to Europe’s Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology (2020) (12)
A study on the structural features of SELK, an over-expressed protein in hepatocellular carcinoma, by molecular dynamics simulations in a lipid-water system. (2016) (12)
Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting (2018) (12)
Leptin receptor-mediated regulation of cholinergic neurotransmitter phenotype in cells of central nervous system origin. (2000) (12)
BMI and breast cancer prognosis benefit: mammography screening reveals differences between normal weight and overweight women. (2015) (12)
Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition (2021) (12)
Cancer mortality trends between 1988 and 2009 in the metropolitan area of Naples and Caserta, Southern Italy (2013) (12)
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp 41 epitope (2005) (12)
Predictive signatures inform the effective repurposing of Decitabine to treat K-RAS-dependent Pancreatic Ductal Adenocarcinoma. (2019) (11)
Deducing the functional characteristics of the human selenoprotein SELK from the structural properties of its intrinsically disordered C-terminal domain. (2016) (11)
Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes (2017) (11)
Adenovirus-mediated gene transfer of a human IL-6 antagonist (1997) (11)
Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies (2021) (11)
Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios (2019) (11)
MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab (2014) (11)
Genetic vaccines against Ep‐CAM break tolerance to self in a limited subset of subjects: Initial identification of predictive biomarkers (2006) (11)
Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women. (2016) (11)
The Elapsed Time During a Virtual Reality Treatment for Stressful Procedures. A Pool Analysis on Breast Cancer Patients During Chemotherapy (2016) (11)
B4GALT1 Is a New Candidate to Maintain the Stemness of Lung Cancer Stem Cells (2019) (11)
Breast cancer surgery during the Covid-19 pandemic: a monocentre experience from the Regina Elena National Cancer Institute of Rome (2020) (11)
Harnessing the Immune System to Fight Cancer: The Promise of Genetic Cancer Vaccines (2011) (11)
Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015 (2016) (10)
Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study (2022) (10)
Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion (2019) (10)
Immunoscore: a new possible approach for melanoma classification (2014) (10)
Adenovirus Transduction and Culture Conditions Affect the Immunogenicity of Murine Dendritic Cells (2005) (10)
Patented cancer vaccines: the promising leads (2010) (10)
Processing of eukaryotic tRNA precursors: secondary structure of the precursor specific sequences affects the rate but not the accuracy of processing reactions. (1982) (10)
TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients (2020) (10)
Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer. (2021) (9)
Alliance Against Cancer, the network of Italian cancer centers bridging research and care (2015) (9)
On the connections between cancer stem cells and EMT (2012) (9)
Drug tolerance to target therapy in melanoma revealed at single cell level: What next? (2020) (9)
The Molecular Design of Human IL‐6 Receptor Antagonists a (1995) (9)
Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer (2018) (9)
A bipartite activation domain is responsible for the activity of transcription factor HNF1/LFB1 in cells of hepatic and nonhepatic origin. (1993) (9)
Bringing Onco-Innovation to Europe’s Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine (2020) (9)
Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity (2019) (9)
Synergistic effect of gene‐electro transfer and adjuvant cytokines in increasing the potency of hepatitis C virus genetic vaccination (2008) (9)
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial (2021) (9)
Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants (2020) (9)
Cancer Stem Cells and the Slow Cycling Phenotype: How to Cut the Gordian Knot Driving Resistance to Therapy in Melanoma (2020) (9)
A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phosphatase (SEAP). (1994) (9)
Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth (2016) (8)
Funcitonal activity and chromatin configuration of SV40 enhancer injected in Xenopus laevis oocytes (1985) (8)
Propelling Health Care into the Twenties (2020) (8)
A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave? (2020) (8)
The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma (2021) (8)
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes (2020) (8)
Transcriptional Control of Gene Expression in Hepatic Cells (1993) (7)
Concise Review: Gene of The Month KEAP1-mutant non-small cell lung cancer: the catastrophic failure of a cell-protecting hub. (2022) (7)
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment (2015) (7)
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectives. (2020) (7)
Survival After Surgical Treatment of Lung Cancer Arising in the Population Exposed to Illegal Dumping of Toxic Waste in the Land of Fires ('Terra dei Fuochi') of Southern Italy. (2016) (7)
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real‐world evidence (2020) (7)
Circulating HPV DNA in the Management of Oropharyngeal and Cervical Cancers: Current Knowledge and Future Perspectives (2021) (7)
Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November–2 December, 2017, Naples, Italy) (2018) (7)
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study (2021) (7)
Comparative effects of nifedipine, verapamil, isosorbide dinitrate and propranolol on exercise-induced angina pectoris. (1979) (6)
The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma (2018) (6)
A Zenopus multifinger protein, Xfin, is expressed in specialized cell types and is localized in the cytoplasm (1991) (6)
Cancer patients and coronavirus disease 2019: evidence in context (2020) (6)
The Experience of Oncology Healthcare Providers in the Central Italy during the COVID-19 Lockdown (2020) (6)
Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients (2018) (6)
Erratum: Oncostatin M binds directly to gp130 and behaves as interleukin- 6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors (Journal of Biological Chemistry (1994) 269 (10991- 10996)) (1994) (6)
H-Ras gene takes part to the host immune response to COVID-19 (2021) (6)
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study (2022) (6)
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study (2022) (6)
Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers (2018) (6)
Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer (2018) (6)
ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors (2015) (6)
Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization (2020) (5)
Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer (2021) (5)
The receptor super-antagonist Sant7. (1997) (5)
High yield expression and purification of human endothelin-1. (1994) (5)
COVID-eVax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19 (2021) (5)
Evidence of a SARS-CoV-2 double Spike mutation D614G/S939F potentially affecting immune response of infected subjects (2022) (5)
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop (2019) (5)
mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail Patients (2022) (5)
Phase I-II study of the combination vemurafenib plus peg-interferon in advanced melanoma patients harboring the V600BRAF mutation. (2014) (4)
Accreditation for excellence of cancer research institutes: recommendations from the Italian Network of Comprehensive Cancer Centers. (2013) (4)
A Zn-finger protein, Xfin, is expressed during cone differentiation in the retina of the frog Xenopus laevis. (1993) (4)
An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer (2022) (4)
Corrigendum: Pazopanib in Metastatic Renal Cancer: A “Real-World” Experience at National Cancer Institute “Fondazione G. Pascale” (2016) (4)
Safety and efficacy of a genetic vaccine targeting Telomerase plus chemotherapy for the therapy of canine B-cell lymphoma (2013) (4)
Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care? (2021) (4)
COVID‐19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience (2021) (4)
Isolation and characterization of a tRNA(guanine-7-)-methyltransferase from Salmonella typhimurium (2004) (4)
Volatilome Analysis in Prostate Cancer by Electronic Nose: A Pilot Monocentric Study (2022) (4)
Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors (2020) (4)
COV-BT Ire study: safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with brain tumors (2022) (4)
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting (2021) (4)
Activation of the ErbB3-AKT axis promotes melanoma cell survival and proliferation in response to RAF/MEK inhibition (2014) (4)
KEAP1 -Mutant NSCLC: The Catastrophic Failure of a Cell-Protecting Hub (2022) (4)
Correction: Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences (2017) (4)
TRF2 cooperates with CTCF for controlling the oncomiR-193b-3p in colorectal cancer. (2022) (4)
Melanoma and immunotherapy bridge (2016) (4)
A prokaryotic tRNATyr gene, inactive in Xenopus laevis oocytes, is activated by recombination with an eukaryotic tRNAPro gene. (1982) (4)
Superior Immunologic and Therapeutic Efficacy of a Xenogeneic Genetic Cancer Vaccine Targeting Carcinoembryonic Human Antigen. (2015) (4)
[The effort test in the diagnosis of typical stable effort angina (author's transl)]. (1977) (4)
Efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg (2014) (4)
Activation of gp130 signaling in vivo by the IL‐6 super‐agonist K‐7 / D‐6 accelerates repopulation of lymphoid organs after irradiation (1999) (4)
Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts (2018) (3)
DNA sequence of a pseudogene for human C-reactive protein. (1987) (3)
Functional activity and chromatin configuration of SV40 enhancer injected in Xenopus laevis oocytes. (1985) (3)
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial (2021) (3)
TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients (2020) (3)
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti‐HER2 agents in the real world setting (2019) (3)
New developments in cancer vaccines (2013) (3)
Genetic vaccination by gene electro-transfer in non-human primates (2006) (3)
Functional assay of tRNA molecules transcribed from a purified gene. (1982) (3)
Observational Multicenter Study on the Prognostic Relevance of Coagulation Activation in Risk Assessment and Stratification in Locally Advanced Breast Cancer. Outline of the ARIAS Trial (2020) (3)
Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts (2018) (3)
Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients (2021) (3)
The abscopal effect: efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg (2013) (3)
Erratum to: Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma (2014) (3)
Erratum: Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth (Oncogene (2016) 35 (1143-1152) DOI:10.1038/onc.2015.169) (2016) (3)
Efficacy and safety of 5% lidocaine-medicated plasters in localized pain with neuropathic and/or inflammatory characteristics: an observational, real-world study. (2017) (3)
SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma (2021) (3)
Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts (2017) (3)
Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts (2017) (3)
[Abnormal electrocardiographic changes induced by hypocalcemia secondary to extracorporeal circulation]. (1984) (2)
[Effects of the association of Ca-antagonists with nitroderivatives or betablocking drugs in effort angina pectoris (author's transl)]. (1978) (2)
Definition of a complex binding site for gp130 in human interleukin-6 (IL-6) (1995) (2)
Synthetic peptide vaccines: the quest to develop peptide vaccines for influenza, HIV and Alzheimer's disease. (2009) (2)
Italy: scientists petition against biodynamic farming law (2021) (2)
Mortality trend for liver cancer in a hyperendemic area of hepatitis C virus infection in southern Italy: join-point analysis and comparison with European and Italian data. (2014) (2)
Mesenchymal traits at the convergence of tumor-intrinsic and -extrinsic mechanisms of resistance to immune checkpoint blockers (2017) (2)
Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study (2022) (2)
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting (2019) (2)
A Real-World Systematic Analysis of Driver Mutations’ Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting (2022) (2)
Ligand-dependent Transcription Switches and Their Potential for Gene Therapy (2003) (2)
Safety of third dose of COVID-19 vaccination in frail patients: Results from the prospective Italian VAX4FRAIL study (2022) (2)
Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression (2023) (2)
Effect of adenosylhomocysteine and other analog thioethers on a prokaryotic tRNA (guanine-7)-methyltransferase. (1982) (2)
MiR‐182‐3p targets TRF2 and impairs tumor growth of triple‐negative breast cancer (2022) (2)
Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non-Small-Cell Lung Cancer. (2021) (2)
Abstract A045: Inhibition of tumor growth by combination of metronomic chemotherapy and checkpoint inhibitor with a cancer vaccine (2016) (1)
Abstract B130: Evaluation of novel metronomic chemotherapy and cancer vaccine combinatorial strategy (2016) (1)
Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available (2021) (1)
Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients (2022) (1)
Drug repurposing against COVID-19: focus on anticancer agents (2020) (1)
Multicohort and cross‐platform validation of a prognostic Wnt signature in colorectal cancer (2020) (1)
Intrablastocyst injection with human CD34+/CD133+ cells increase survival of immunocompetent fumarylacetoacetate hydrolase knockout mice (2012) (1)
Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma (2022) (1)
Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma (2018) (1)
Transcription of multimeric tRNA genes. (1984) (1)
224 Her3 as an emerging target for lung tumor initiating cells (2010) (1)
Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition (2020) (1)
Malignant meningioma mTOR mutated and precision medicine (2022) (1)
MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab (2014) (1)
CCAAT enhancer binding protein B is required for Fas-induced apoptosis in liver (2000) (1)
Burnout of health care providers during the COVID-19 pandemic: Focus on Medical Oncologists (2021) (1)
Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion (2019) (1)
Drug Repurposing to Target the Apoptosome in MAPKi-Resistant Melanoma (2021) (1)
Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer (2022) (1)
KEAP1 and TP53 Mutations in Lung Cancer: More Is Better. Reply to: "Survival Analysis of TP53 Co-Mutations Should Be Interpreted More Cautiously". (2022) (1)
Emerging therapeutics (2021) (1)
Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients (2014) (1)
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration (2022) (1)
Regulation of C-Reactive Protein, Haptoglobin, and Hemopexin Gene Expression (2020) (1)
Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies (2013) (1)
Molecular dissection of a hyper-aggressive CBFB-MYH11/FLT3-ITD–positive acute myeloid leukemia (2022) (1)
Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol (2022) (1)
Immunoscore as new possible approach for the classification of melanoma. (2014) (1)
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters (2022) (1)
ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors (2015) (1)
The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment (2013) (1)
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study (2022) (1)
Thymic Epithelial Tumors as a Model of Networking: Development of a Synergistic Strategy for Clinical and Translational Research Purposes (2020) (1)
Abstract 1070: miR-579-3p is a novel master regulator of melanoma progression and drug resistance in metastatic melanoma (2016) (1)
[Mutational oncology of lung cancer: molecular markers, drugs, negotiation conditions and experiences in national reference centers.] (2021) (1)
Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer (2019) (1)
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions (2022) (1)
Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors (2013) (1)
Reorganization of Istituti Fisioterapici Ospitalieri, an oncological and dermatological clinical and research center, to face the coronavirus health emergency: adopted measures and metrics of success to achieve and keep a COVID-19-free status (2020) (1)
Tumor biobanks in translational medicine (2012) (1)
The limitations of echocardiography in the overall diagnosis of the morphological lesions associated with infective endocarditis: comparison of echocardiographic and surgical findings. (1999) (1)
Does Interleukin-6 Bridge SARS-CoV-2 With Virus-Associated Cancers? (2021) (1)
A Prospective Study Evaluating Health-Related Quality of Life Following a Multimodal Treatment for Colorectal Cancer (2022) (1)
EP-1392: The abscopal effect:efficacy of radiotherapy in patients on progression after ipilimumab 3 mg/kg (2016) (1)
[Effectiveness of nifedipine on exercise tolerance in patients with angina pectoris. Comparison with a nitroderivative and a beta-blocking agent]. (1977) (1)
Optimizing the Illumina COVIDSeq laboratorial and bioinformatics pipeline on thousands of samples for SARS-CoV-2 Variants of Concern tracking (2022) (1)
Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity (2016) (1)
A welcome revision, but organic farming law still needs work (2022) (1)
Muteins of wild type cytokines and their use as immunogenic (1996) (0)
Melanoma and immunotherapy bridge 2015 (2016) (0)
Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants (2020) (0)
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment (2015) (0)
Neoantigen cancer vaccine augments anti-CTLA-4 efficacy (2022) (0)
IL-1 induces transcription factor NF-kB in hepatoma cells (1990) (0)
Expression of recombinant human lipocortin V in vaccinia virus (1990) (0)
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment (2014) (0)
Composition based on active ingredients from medicinal plants for the treatment and prevention of hair loss in men and women (2011) (0)
Efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg (2014) (0)
A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave? (2020) (0)
Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study (2018) (0)
Molecular characterization of spheroid cultures from lung adenocarcinoma pleural effusion (2011) (0)
Characterization of the activation domain and post-translational modification of IL-6DBP necessary for induction of acute-phase gene transcription by IL-6 (1991) (0)
Primary cardiac tumors: Surgical treatment and late results (1992) (0)
P127 Metabolic syndrome and breast cancer risk by molecular subtype (2015) (0)
Sexual dysfunctions in breast cancer patients: evidence in context. (2023) (0)
Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November–2 December, 2017, Naples, Italy) (2018) (0)
Volume 11 Number 12 1983 Nucleic Acids Research A general method to select for M 13 clones carrying base pair substitution mutants constructed in vitro (2004) (0)
HER2 Nuclear Translocation and Decreased T-DM1 Efficacy in HER2 Positive Advanced Breast Cancer Treated with Dual HER2 Blockade. The SePHER Study. (2020) (0)
Animal Model Hepatocellular Hyperplasia, Plasmacytoma Formation, and Extramedullary Hematopoiesis in Interleukin (IL)-6/Soluble IL-6 Receptor Double-Transgenic Mice (1998) (0)
A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice (2016) (0)
Apoptotic cell death in disease—Current understanding of the NCCD 2023 (2023) (0)
Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization (2020) (0)
Look for methods, not conclusions (2019) (0)
(Recombinant DNA; oligodeoxyribonucleotide-directed mutagenesis; N-glycosylation; cytokine; conformation-specific immunoprecipitation; mutated proteins) (1991) (0)
Solution ensemble structures of HIV-1 gp41 2F5 mAb epitope (2003) (0)
A chimpanzee serotype-based adenoviral vector as vaccine for CEA (2006) (0)
Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”: Napoli, December 3rd–6th 2014 (2015) (0)
Corrigendum to "Coadministration of Telomerase Genetic Vaccine and a Novel TLR9 Agonist in Nonhuman Primates". (2010) (0)
Breast cancer screening, body mass index and prognosis benefit (2014) (0)
Engineering humaninterleukin-6 toobtain variants withstrongly enhanced bioactivity (1996) (0)
Abstract 742: A novel multidrug metronomic chemotherapy significantly delays tumor growth in mice (2016) (0)
Clinical and echocardiographic long term follow-up after ablation of the AV junction: Comparison between paroxysmal and chronic atrial tachyarrhythmias (1993) (0)
AB044. PS02.08: Surgery for TET in the era of translational research: towards a workflow model incorporating the biobank (2017) (0)
Comparing the fluctuations of the intrinsically disordered C-terminal domain of human SELK free in water and in lipid membrane (2015) (0)
Errata and Corrigenda (2001) (0)
Companion vaccine Bioinformatic design tool reveals limited functional genomic variability of SARS-Cov-2 Spike Receptor Binding Domain (2020) (0)
EPIDEMIOLOGY, GENETICS AND PATHOGENESIS A01 FAMILIAL MELANOMA AND MULTIPLE PRIMARY MELANOMA: ANALYSIS OF PREDISPOSING GENETIC MUTATIONS IN 190 PATIENTS (2021) (0)
The methodology for selecting superagonists, antagonists and super- hormone antagonists of the receptor complex which is part gp 130. (1993) (0)
Reorganization of Istituti Fisioterapici Ospitalieri, an oncological and dermatological clinical and research center, to face the coronavirus health emergency: adopted measures and metrics of success to achieve and keep a COVID-19-free status (2020) (0)
Bringing onco-innovation to Europe’s healthcare systems: the unexploited potential of biomarker testing, real world evidence and the potential of Tumour Agnostics. The lesson from BRCA1/2 genetic testing (2020) (0)
The impact of the COVID-19 pandemic on diagnosis and treatment of patients with soft tissue and bone sarcomas or aggressive benign musculoskeletal diseases: A single-center retrospective study (SarCorD study) (2022) (0)
The need for a network to establish and validate predictive biomarkers in cancer immunotherapy (2017) (0)
SCD1, autophagy and cancer: implications for therapy (2021) (0)
Genomes Over a Lifetime (GOAL): An innovative approach to personalized patient empowerment through early diagnosis and treatment for cancer patients and rare disease (2023) (0)
Adenosylmethionine as a Precursor for Nucleic Acids Modification (1980) (0)
[Orally administered nitroderivates: efficacy and duration of the effects of isosorbide dinitrate (author's transl)]. (1976) (0)
Antagonists of interleukin-6 (IL-6) that consist of the soluble forms of the receptor alpha-6, changing the interface that binds to gp 130 (1994) (0)
Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells (2017) (0)
Abstract 5444: Modulation of ErbB receptors expression by histone deacetylase inhibitors increased the antitumor activity of an anti-ErbB3 monoclonal antibody in primary cultures from non-small cell lung cancer patients (2014) (0)
A novel mouse model for identification of HLA-A2.1 epitopes and evaluation of CEA cancer vaccine (2006) (0)
Liver-specific and inducible expression of oncogenes in transgenic mice (1990) (0)
C-reactive protein gene expression is under control of transcription factor HNF1 (1990) (0)
Targeting the MITF/APAF-1 axis as salvage therapy for MAPK inhibitors in resistant melanoma. (2022) (0)
Errata and corrigenda (2002) (0)
Cancer patients and coronavirus disease 2019: evidence in context (2020) (0)
The use of a vaccine targeting telomerase reverse transcriptase (TERT) in healthy dogs and in dogs affected by malignant lymphoma (2009) (0)
Low Glycemic Index Diet, Exercise and Vitamin D to Reduce Breast Cancer Recurrence: Rationale for the Design of a Clinical Trial (2016) (0)
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions (2022) (0)
H-Ras gene takes part to the host immune response to COVID-19 (2021) (0)
Antagonists human interleukin-6 is completely incapable of binding gp130 and its use in the preparation of pharmaceutical compounds. (1996) (0)
The use of genetic markers for the selection and the allelic exchange of "in vitro" induced mutations that do not have a phenotype in E. coli. (1984) (0)
Determination of individual genetic pattern by analysis of hypervariable minisatellites as a new method for establishment of paternity. General considerations and descriptions of a disputed case (1988) (0)
Issue Information‐ToC (2020) (0)
262 Immunization with genetic vectors expressing rhesus CEA efficiently breaks immune tolerance in mice and rhesus monkeys (2004) (0)
GENE/NUCLEOTIDE THERAPY Therapeutic Genetic Vaccination Against the ECDTM Domain of Rather2/Neu Results in Prevention of Tumor Development or Stabilization of Disease in BALB/NEUT Mice (2006) (0)
Unusual phylogenetic tree and circulating actionable ESR1 mutations in an aggressive luminal/HER2-low breast cancer: Case report (2023) (0)
Impact of COVID-19 pandemic on outpatient visit volume in cancer patients: Results of COMETA multicenter retrospective observational study (2023) (0)
Activation of the ErbB3-AKT axis promotes melanoma cell survival and proliferation in response to RAF/MEK inhibition (2014) (0)
SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma (2022) (0)
Volume 12 Number 2 1984 Nucleic Acids Research Transcription of mulu ' meric tRNA genes (2005) (0)
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study (2020) (0)
The use of single locus and multilocus minisatellite probes to diagnose specific individuality. (1989) (0)
Future perspectives in melanoma research “Melanoma Bridge”, Napoli, November 30th–3rd December 2016 (2017) (0)
The perfect personalized cancer therapy: cancer vaccines against neoantigens (2018) (0)
AllergensProduction Induced by Inhaled Fungal IL-6 Is Required for Airway Mucus (2009) (0)
Safety and Efficacy of a Genetic Vaccine targeting Telomerase against various canine cancers (2012) (0)
Identification of a Novel HIV-1 Neutralizing Antibody Using Synthetic Peptides that Mimic a GP41 Fusion Intermediate (2006) (0)
Alliance Against Cancer, the network of Italian cancer centers bridging research and care (2015) (0)
Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer (2021) (0)
Emerging therapeutics (2021) (0)
Generation of IL-6 receptor antagonist and super-antagonist by molecular modelling and site-directed mutagenesis (1994) (0)
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013 (2014) (0)
Abstract A207: PD-1-functionality and CD28 molecule expression in CD8+ T-cells of cancer patients (2019) (0)
[The sick sinus syndrome: follow-up of 100 paced patients (author's transl)]. (1978) (0)
Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study (2015) (0)
[The significance of ventricular arrhythmias during muscular work: correlations with coronary heart disease (author's transl)]. (1977) (0)
Long-Term Persistence and Relevant Therapeutic Impact of High-Titer Viral-Neutralizing Antibody in a Convalescent COVID-19 Plasma Super-Donor: A Case Report (2021) (0)
IL6fl, are induced by IL-6 to promote acute phase gene transcription via different mechanisms (0)
Murine interleukin-6 receptor: Cloning and expression (1990) (0)
Chemotherapy and telomerase vaccine as novel approach to manage Canine Lymphoma (2012) (0)
The emerging role of cancer cell plasticity and cell-cycle quiescence in immune escape (2020) (0)
Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach (2023) (0)
Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research (2017) (0)
Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer (2023) (0)
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis (2023) (0)
Structure-function studies on human interleukin-6 (1989) (0)
PD52-02 HUMAN VOLATILOME ANALYSIS OF PATIENTS WITH RENAL CELL CARCINOMA: PROSPECTIVE, TWO-ARM NON-RANDOMIZED MONOCENTRIC STUDY (2021) (0)
Abstract 2846: Exploring ERBB3 as novel drug target in lung cancer (2012) (0)
The organization of clinical trials for oncology at IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale" Napoli and the impact of the OECI accreditation process. (2015) (0)
Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study (2020) (0)
The Glioma-IRE project − Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach (2023) (0)
Abstract 248: Stearoyl-CoA desaturase 1 is a key factor for lung cancer stem cell survival and expansion. (2013) (0)
An interaction network approach to study the correlation between endocrine disrupting chemicals and breast cancer. (2017) (0)
TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients (2020) (0)
Future perspectives in melanoma research (2016) (0)
Abstract 4230: Targeting lung cancer stem cells through fatty acid metabolism (2015) (0)
The role of CRP and IL-6 in unstable angina - Response (1997) (0)
Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience (2013) (0)
Corrigendum: Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale". (2016) (0)
Surgical Site Infections in Breast Cancer Patients Undergoing Surgery During the Covid-19 Pandemic. Preliminary Data from an Italian Oncologic Hub. (2021) (0)
Virus DNA Vaccine in Nonhuman Primates by Gene Electrotransfer of a Hepatitis C Modulation of the Immune Response Induced (2006) (0)
Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth (2019) (0)
Fusion protein to carcinoembryonic antigen and their uses (2005) (0)
Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression (2017) (0)
Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for B-cell canine lymphoma therapy (2013) (0)
Expression and localization of a Zinc-finger gene product during development in Xenopus (1990) (0)
Ten-Year Clinical and Angiographic Follow-Up of Coronary Wallstent (2000) (0)
Human Urinary Volatilome Analysis in Renal Cancer by Electronic Nose (2023) (0)
Abstract 1690: Epitope-minigenes for optimal induction of the immune response against tumor associated antigens and neoantigens (2017) (0)
Identification of the biological father by means of DNA hypervariable minisatellites in a case of incest (1989) (0)
Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer (2018) (0)
Synergism of phorbol esters with interleukin 1β on interleukin 6 release and gene expression in rat cortical astrocytes (1995) (0)
Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012” (2013) (0)
Antagonists of human interleukin-6, which are incapable of binding with gp 130 and compositions their use in the manufacture of pharmaceutical (1996) (0)
gene is composed of three (2016) (0)
The Organization of Clinical Trials for Oncology at IRCCS Istituto Nazionale Tumori “Fondazione G. Pascale” Napoli and the Impact of the OECI Accreditation Process (2015) (0)
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas (2017) (0)
Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers (2018) (0)
12. Is metabolic syndrome-breast cancer link relatable to specific molecular subtype? (2014) (0)
Developmental expression of the Zinc-finger protein Xfin in Xenopus (1990) (0)
Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial (2017) (0)
Melanoma Bridge 2013: Poster and Oral Presentations (2014) (0)
Antagonist hIL-6-Transgenic Mice with a hIL-6 Receptor ( hIL-6 ) Achieved by Immunization of In Vivo Neutralization of Human IL-6 (2001) (0)
Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting (2018) (0)
The linkage of human circadian rhythms and hepatocellular carcinoma (HCC) through network analysis (2015) (0)
Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies (2021) (0)
Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma (2018) (0)
Table of Contents (1994) (0)
B4GALT1 as a New Biomarker of Idiopathic Pulmonary Fibrosis (2022) (0)
[Dynamic ECG in patients surgically treated for interatrial defect: observations on 36 cases]. (1981) (0)
Internal deletions of amino acids 29–42 of human interleukin‐6 (IL‐6) differentially affect bioactivity and folding (1991) (1991) (0)
Abstract 291: Targeting the stroma to hit the tumor: MMP11 as a novel target for cancer immunotherapy (2015) (0)
[Critical stenoses of the common trunk of the left coronary artery]. (1978) (0)
Research Choices: Time for Europe to Decide (2017) (0)
Muteins using wild-type cytokine as immunogens. (1996) (0)
Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts (2018) (0)
[Arrhythmias in patients with interatrial defect: pre- and post-operative study with dynamic ECG]. (1981) (0)
Caused by Carrageenan Role of IL-6 in the Pleurisy and Lung Injury (1999) (0)
Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts (2018) (0)
Immunization with genetic vectors expressing rhesus CEA efficiently breaks immune tolerance in mice and rhesus monkeys (2005) (0)
Breast cancer surgery during the Covid-19 pandemic: a monocentre experience from the Regina Elena National Cancer Institute of Rome (2020) (0)
ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinoma. (2023) (0)
TLR9 agonists enhance the efficacy of cancer vaccines (2008) (0)
Method to select superagonists, antagonists and superantagonists of hormones whose receptor complex is part gp 130 (1994) (0)
A process for the production of interleukin-6 (1992) (0)
Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts (2017) (0)
[Long-term effects of sublingual isosorbide dinitrate (author's transl)]. (1976) (0)
Abstract 2846: Safety and efficacy of a genetic vaccine targeting telomerasepluschemotherapy for the therapy of canine B-cell lymphoma . (2013) (0)
Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracy (2019) (0)
Molecular dissection of a hyper-aggressive CBFB-MYH11/FLT3-ITD–positive acute myeloid leukemia (2022) (0)
Light at the end of the canaliculus. First Instituto Ricerche di Biologia Molecolare Symposium on Gene Expression During Liver Differentiation and Disease, Sorrento, Italy, June 2-6, 1991. (1991) (0)
Overcoming anti-melanoma drug resistance with reverse transcriptase inhibitors (RTIs) (2020) (0)
A maternally expressed zinc-finger protein in Xenopus (1990) (0)
A prognostic score from a multicentric retrospective analysis of patients affected by sarcoma with metachronous lung metastases undergoing metastasectomy (2023) (0)
Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations (2018) (0)
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy (2018) (0)
Abstract 1052: Stearoyl-CoA-Desaturase (SCD1) regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ (2016) (0)
Issue Information‐ToC (2019) (0)
The use of a vaccine targeting telomerase reverse transcriptase (TERT) in dogs affected by malignant lymphoma (2010) (0)
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance (2022) (0)
Structure andexpression ofa Xenopusgene encoding an snRNPprotein (Ul70K) (1988) (0)
Multidimensional C-13, N-15 heteronuclear NMR-Spectroscopy of the H-interleukin-6 (1995) (0)
Theaffinity-selecti on ofa minibody polypeptide inhibitor ofhumaninterleukin-6 (1994) (0)
Abstract P4-01-19: Liquid biopsy and re-biopsy: Tracking mutational trajectories in HER2+breast cancer patients undergoing T-DM1 treatment (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gennaro Ciliberto?

Gennaro Ciliberto is affiliated with the following schools: